Skip to Main Content

Paper Details

Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis.
Neuro Oncol
11
2022
-driven cells, HUVECs, LDHA, MB, MB cells, MBs, MYC, MYC-driven, MYC-driven cells, WNT, cancer, dickkopf, high, high-, high-risk medulloblastomas, inhibitor, inhibitor 3, lactate, lactate dehydrogenase A, medulloblastoma, non-, non-MYC-driven cells, proto-oncogene MYC, tumor, tumor cell, vitro isogenic cell models
Author NameAffiliation
Nan Qin
Nan Qinand Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Nan QinInstitute of Neuropathology
Daniel Picard
Daniel Picardand Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Daniel PicardInstitute of Neuropathology
Frauke-Dorothee Meyer
Frauke-Dorothee Meyerand Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Frauke-Dorothee MeyerInstitute of Neuropathology
Lena Bl??mel
Lena Bl??meland Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Lena Bl??melInstitute of Neuropathology
Sarah G??bbels
Sarah G??bbelsand Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Sarah G??bbelsInstitute of Neuropathology
Jasmin Bartl
Jasmin Bartland Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Jasmin BartlInstitute of Neuropathology
Anja StefanskiBiomedical Research Center (BMFZ), Heinrich Heine University
St??phanie PugetNecker Hospital, Paris Descartes University
St??phanie PugetNecker Hospital, Paris Descartes University
Kai St??hlerInstitute for Molecular Medicine I, Heinrich Heine University, University Hospital Dusseldorf
Kai St??hlerBiomedical Research Center (BMFZ), Heinrich Heine University
Ute Fischerand Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Olivier AyraultInstitut Curie, PSL Research University, Universite Paris Sud, Universite Paris-Saclay
Guido Reifenberger
Guido ReifenbergerInstitute of Neuropathology
Arndt Borkhardtand Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Arndt Borkhardtand Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Claudia C FariaInstituto de Medicina Molecular - Joao Lobo Antunes, Faculdade de Medicina da Universidade de Lisboa
Claudia C FariaHospital Santa Maria, Centro Hospitalar Lisboa Norte
Marc Remke
Marc Remkeand Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Marc RemkeInstitute of Neuropathology
  • 1 - 34

Datasets